Russia’s Federal Antimonopoly Service (FAS) has granted an approval for the merger of German chemical company Bayer and US producer of genetically modified seeds and herbicides Monsanto Company, Igor Artemyev, head of the FAS, said.
Russia was one of the few jurisdictions to be won over after the European Commission last month gave conditional clearance and after a source said Bayer struck an agreement in principle with the US Department of Justice.
“Bayer has agreed to enable the transfer of defined technologies to Russian recipients in the area of seeds breeding and digital farming for a period of five years,” the company said in a statement.
As part of these concessions, Bayer will share some genetic know-how on corn, wheat, oil seed rape, soybean and vegetable seeds. It would also grant “non-discriminatory” access to digital farming technologies once they were available in Russia, Bayer said.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI